FDAnews Drug Daily Bulletin

NEW DRUGS WILL HELP DRIVE THE PRESCRIPTION PAIN TREATMENT MARKET TO $50 BILLION IN 2020

May 31, 2006
A A

Decision Resources, Inc., one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that new first-in-class treatments, including drugs from Vertex/GlaxoSmithKline, Rinat Neuroscience, Avigen, and Pharmos will expand the market to treat pain in the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan to nearly $50 billion in 2020.
PR Newswire